A new clinical trial demonstrates that hepatocyte growth factor plasmid therapy with AMG0001 is a promising, nonsurgical ...

TheFly reported on December 15 that Barclays raised its price target for TWST from $37 to $39 while maintaining an Overweight ...

This paper presents an important advance in genetically encoded voltage imaging of the developing zebrafish spinal cord in vivo, capturing voltage dynamics in neuronal populations, single cells, and ...

Antibiotic resistance is a major global health threat, complicating the treatment of common infections. This PhD thesis explored how antibiotic resistance spreads beyond the farm environment, linking ...

Rising demand for gene and cell therapies, expanding mRNA vaccine pipelines, and increasing investments in GMP-compliant manufacturing facilities are driving growth in the viral vectors and plasmid ...

New formulations simplify microbial bioprocessing, helping innovators scale plasmid DNA and protein production with confidenceWALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world ...

Thermo Fisher Scientific Inc. has introduced Gibco Bacto CD Supreme FPM Plus and Gibco Bacto CD Supreme Feed (2X).

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of Gibco(TM) Bacto(TM) CD Supreme FPM Plus and Gibco(TM) Bacto(TM) CD Supreme Feed (2X), two ...

1 MikroIker Research Group, Faculty of Pharmacy, University of the Basque Country UPV/EHU - Vitoria-Gasteiz, Vitoria-Gasteiz, Spain 2 German Federal Institute for Risk Assessment, Berlin, Germany The ...

Twist Bioscience (TWST) just rolled out research grade Plasmid DNA Preps tailored for pre clinical pharma and biotech work, a small but telling move that helps explain the recent uptick in the stock.